HLS:TSX, HLS Therapeutics Inc.

HLS stock overview

HLS Therapeutics Inc. (HLS:TSX) closed at $4.33 on October 23, 2026, up 4.34% on the day. The stock trades 23.0% below its 52-week high of $5.62 and 432,900.0% above its 52-week low of $0.001. Over the past year, it lost 22.7%. HLS Therapeutics Inc. is part of the Health Care sector.

Key figures

Price
$4.33
Day change
+4.34%
Volume
125,900
Average volume
68,841
Market cap
133M+
52-week range
$0.001 – $5.62
50-day average
$3.94
200-day average
$4.32

Price action over the past year

In 252 trading sessions since October 23, 2025, HLS closed higher on 83 days (33%). Its best day was October 5, 2026 (+8.79%) and its worst was November 13, 2025 (-7.59%). It never moved 10% or more in a single session. It opened at least 5% above the previous day's high 3 times.

Recent signals

HLS news

About HLS Therapeutics Inc.

HLS Therapeutics Inc, formerly Automodular Corp, is a specialty pharmaceutical company focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets.

Similar stocks

Find more stocks like HLS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.